Get the Stockscreener App
1.07
5.31%
-0.06
After Hours:
1.07
AEON Biopharma Inc. stock is traded at $1.07, with a volume of 421.02K.
It is down -5.31% in the last 24 hours and up +37.18% over the past month.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$1.13
Open:
$1.14
24h Volume:
421.02K
Relative Volume:
3.09
Market Cap:
$12.46M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+25.88%
1M Performance:
+37.18%
6M Performance:
+167.50%
1Y Performance:
-98.51%
1-Day Range:
$1.06
$1.20
1-Week Range:
$0.8402
$1.20
52-Week Range:
$0.375
$83.52
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.
Sector
Industry
Phone
(949) 354-6499
Address
5 Park Plaza, Suite 1750, Irvine
Compare AEON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
1.07 | 13.16M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-23 | Initiated | H.C. Wainwright | Buy |
AEON Biopharma Inc. Stock (AEON) Latest News
What Fibonacci levels say about AEON Biopharma Inc. rebound2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com
Will AEON Biopharma Inc. outperform the market2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
Applying Wyckoff theory to AEON Biopharma Inc. stockJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
What MACD signals say about AEON Biopharma Inc.July 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
Why institutional investors increase stakes in AEON Biopharma Inc. Class stockTrade Exit Report & Fast Exit Strategy with Risk Control - newser.com
Will AEON Biopharma Inc. see short term momentumNew Guidance & Intraday High Probability Alerts - newser.com
Is AEON Biopharma Inc. stock attractive for ETFsWeekly Gains Summary & High Conviction Trade Alerts - newser.com
What hedge fund moves indicate for AEON Biopharma Inc. Class stockMarket Growth Report & Community Consensus Stock Picks - newser.com
AEON Biopharma announces CEO appointment - MSN
What catalysts could drive AEON Biopharma Inc. stock higherJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com
How AEON Biopharma Inc. stock reacts to global recession fearsJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
What MACD and RSI say about AEON Biopharma Inc.Weekly Investment Recap & Smart Money Movement Tracker - newser.com
Key resistance and support levels for AEON Biopharma Inc.Trade Volume Report & Safe Entry Zone Identification - newser.com
AEON Biopharma Inc Stock Analysis and ForecastRSI Overbought/Oversold & Today’s Picks, Tomorrow’s Winners - earlytimes.in
AEON Biopharma (AEON) Receives Reiterated 'Buy' Rating from Aegi - GuruFocus
AEON Biopharma Sets FDA Meeting To Advance Botox Biosimilar ABP-450 - insights.citeline.com
Using Bollinger Bands to evaluate AEON Biopharma Inc.Profit Target & Weekly Market Pulse Alerts - newser.com
Can AEON Biopharma Inc. Class stock expand revenue streamsPortfolio Profit Report & Breakout Confirmation Alerts - newser.com
Published on: 2025-10-06 04:55:25 - newser.com
Market reaction to AEON Biopharma Inc.’s recent newsTrade Analysis Summary & Real-Time Price Movement Reports - newser.com
Order flow analysis tools used on AEON Biopharma Inc.Market Weekly Review & Expert Curated Trade Ideas - newser.com
Technical analysis overview for AEON Biopharma Inc. stock2025 Key Lessons & Consistent Growth Equity Picks - newser.com
Published on: 2025-10-05 06:00:56 - newser.com
How AEON Biopharma Inc. Class stock responds to job market shiftsWeekly Profit Analysis & Technical Confirmation Alerts - newser.com
Is AEON Biopharma Inc. stock a safe buy before earningsWeekly Market Outlook & Precise Buy Zone Tips - newser.com
Published on: 2025-10-03 06:36:26 - newser.com
How to use Fibonacci retracement on AEON Biopharma Inc.2025 Earnings Impact & Fast Moving Trade Plans - newser.com
Using R and stats models for AEON Biopharma Inc. forecastingQuarterly Profit Summary & High Accuracy Trade Signal Alerts - newser.com
Head to Head Analysis: AEON Biopharma (NASDAQ:AEON) versus Comera Life Sciences (NASDAQ:CMRA) - Defense World
Migraine Market Growth to Surge During Forecast Period (2024–2034), Says DelveInsight | Eli Lilly and Company, Teva Pharmaceuticals, Axsome Therapeutics, AEON Biopharma, Inc., Charleston Laboratories - Barchart.com
Published on: 2025-10-01 09:36:45 - newser.com
AEON Biopharma Inc. Stock (AEON) Financials Data
There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
AEON Biopharma Inc. Stock (AEON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FISCHER JOST | Director |
May 20 '25 |
Buy |
0.51 |
60,000 |
30,360 |
206,785 |
| FISCHER JOST | Director |
May 19 '25 |
Buy |
0.50 |
50,000 |
24,940 |
146,785 |
1.11%
Cap:
|
Volume (24h):